A study to investigate how effective and safe the study medication ‘mirabegron’ is and how long it stays in the body in children and adolescents aged 3 to less than 18 years with symptoms of an overac...

Mise à jour : Il y a 4 ans
Référence : EUCTR2015-002876-25

A study to investigate how effective and safe the study medication ‘mirabegron’ is and how long it stays in the body in children and adolescents aged 3 to less than 18 years with symptoms of an overactive bladder with a neurologic cause

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To evaluate the efficacy of mirabegron after multiple-dose administration in the pediatric population.


Critère d'inclusion

  • Neurogenic Detrusor Overactivity (NDO)